GlaxoSmithKline

GlaxoSmithKline

GlaxoSmithKline (GSK)GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit www.gsk.com.

GlaxoSmithKline RSS Channel

Filters
List of articles in category GlaxoSmithKline
Title Published Date
Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19 07 October 2020
Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine 23 September 2020
Vir Biotechnology and GSK start phase 2/3 study of COVID-19 antibody treatment 31 August 2020
Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine 04 August 2020
GSK and CureVac announce strategic mRNA technology collaboration 21 July 2020
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine 07 July 2020
GSK COVID-19 vaccine development collaboration with Clover Biopharmaceuticals begins clinical trials 26 June 2020
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19 20 April 2020
Clover and GSK announce research collaboration to evaluate coronavirus (COVID-19) vaccine candidate with pandemic adjuvant system 24 February 2020
GSK completes transaction with Pfizer to form new world-leading Consumer Healthcare Joint Venture 05 August 2019
GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company 06 December 2018
GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics 12 April 2018
GSK reaches agreement with Novartis to acquire full ownership of Consumer Healthcare Business 28 March 2018
Where do you start when developing a new medicine? 26 March 2014
ViiV Healthcare's new HIV medicine TivicayTM (dolutegravir) is approved in Europe 22 January 2014
GSK and Theravance announce regulatory submission for ANORO™ (UMEC/VI) 09 January 2013
GSK announces submission for a new indication for Synflorix™ 20 September 2012
European Commission grants marketing authorisation for pazopanib (Votrient®) in the treatment of certain advanced soft tissue sarcoma subtypes 08 August 2012
GSK statement on BBC Panorama: "The truth about Sports Products" 23 July 2012
GSK statement on BBC Panorama broadcast: 'the truth about tax' 14 May 2012